XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings (accumulated deficit)
Beginning balance at Dec. 31, 2018 $ 112,259   $ 757,314 $ (1,400) $ (643,655)
Beginning balance (in shares) at Dec. 31, 2018   93,254,185      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation to employees 9,649   9,649    
Exercise of options and warrants and vested RSUs 16,978   16,978    
Exercise of options and warrants and vested RSUs (in shares)   2,438,612      
Other comprehensive income (loss), net of tax benefit (342)     (342)  
Net income (loss) (12,150)       (12,150)
Ending balance at Mar. 31, 2019 126,394   783,941 (1,742) (655,805)
Ending balance (in shares) at Mar. 31, 2019   95,692,797      
Beginning balance at Dec. 31, 2018 112,259   757,314 (1,400) (643,655)
Beginning balance (in shares) at Dec. 31, 2018   93,254,185      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (11,490)        
Ending balance at Sep. 30, 2019 190,365   848,151 (2,641) (655,145)
Ending balance (in shares) at Sep. 30, 2019   98,948,935      
Beginning balance at Dec. 31, 2018 112,259   757,314 (1,400) (643,655)
Beginning balance (in shares) at Dec. 31, 2018   93,254,185      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (7,230)        
Ending balance at Dec. 31, 2019 217,790   871,442 (2,767) (650,885)
Ending balance (in shares) at Dec. 31, 2019   99,528,435      
Beginning balance at Mar. 31, 2019 126,394   783,941 (1,742) (655,805)
Beginning balance (in shares) at Mar. 31, 2019   95,692,797      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation to employees 13,732   13,732    
Proceeds from issuance of shares 1,208   1,208    
Proceeds from issuance of shares (in shares)   43,421      
Exercise of options and warrants and vested RSUs 19,457   19,457    
Exercise of options and warrants and vested RSUs (in shares)   2,122,658      
Other comprehensive income (loss), net of tax benefit (615)     (615)  
Net income (loss) (1,270)       (1,270)
Ending balance at Jun. 30, 2019 158,906   818,338 (2,357) (657,075)
Ending balance (in shares) at Jun. 30, 2019   97,858,876      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation to employees 14,338   14,338    
Exercise of options and warrants and vested RSUs 15,475   15,475    
Exercise of options and warrants and vested RSUs (in shares)   1,090,059      
Other comprehensive income (loss), net of tax benefit (284)     (284)  
Net income (loss) 1,930       1,930
Ending balance at Sep. 30, 2019 190,365   848,151 (2,641) (655,145)
Ending balance (in shares) at Sep. 30, 2019   98,948,935      
Beginning balance at Dec. 31, 2019 217,790   871,442 (2,767) (650,885)
Beginning balance (in shares) at Dec. 31, 2019   99,528,435      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation to employees 16,557   16,557    
Exercise of options and vested RSUs 4,511   4,511    
Exercise of options and vested RSUs (in shares)   834,538      
Other comprehensive income (loss), net of tax benefit (862)     (862)  
Net income (loss) 3,952       3,952
Ending balance at Mar. 31, 2020 241,948   892,510 (3,629) (646,933)
Ending balance (in shares) at Mar. 31, 2020   100,362,973      
Beginning balance at Dec. 31, 2019 217,790   871,442 (2,767) (650,885)
Beginning balance (in shares) at Dec. 31, 2019   99,528,435      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 14,891        
Ending balance at Sep. 30, 2020 307,037   946,267 (3,236) (635,994)
Ending balance (in shares) at Sep. 30, 2020   101,728,327      
Beginning balance at Mar. 31, 2020 241,948   892,510 (3,629) (646,933)
Beginning balance (in shares) at Mar. 31, 2020   100,362,973      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation to employees 18,770   18,770    
Proceeds from issuance of shares 1,667   1,667    
Proceeds from issuance of shares (in shares)   33,075      
Exercise of options and vested RSUs 3,685   3,685    
Exercise of options and vested RSUs (in shares)   624,673      
Other comprehensive income (loss), net of tax benefit 97     97  
Net income (loss) 1,655       1,655
Ending balance at Jun. 30, 2020 267,822   916,632 (3,532) (645,278)
Ending balance (in shares) at Jun. 30, 2020   101,020,721      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation to employees 20,121   20,121    
Exercise of options and vested RSUs 9,514   9,514    
Exercise of options and vested RSUs (in shares)   707,606      
Other comprehensive income (loss), net of tax benefit 296     296  
Net income (loss) 9,284       9,284
Ending balance at Sep. 30, 2020 $ 307,037   $ 946,267 $ (3,236) $ (635,994)
Ending balance (in shares) at Sep. 30, 2020   101,728,327